These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26279178)

  • 1. Well-Being Therapy in a Patient with Panic Disorder Who Failed to Respond to Paroxetine and Cognitive Behavior Therapy.
    Cosci F
    Psychother Psychosom; 2015; 84(5):318-9. PubMed ID: 26279178
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study.
    Stein MB; Ron Norton G; Walker JR; Chartier MJ; Graham R
    Psychiatry Res; 2000 Jul; 94(3):191-200. PubMed ID: 10889283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder.
    Berger P; Sachs G; Amering M; Holzinger A; Bankier B; Katschnig H
    J Affect Disord; 2004 May; 80(1):75-8. PubMed ID: 15094260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11-year-old boy with panic disorder responding to paroxetine.
    Tamai Y; Matsumoto H
    Tokai J Exp Clin Med; 2007 Mar; 32(1):28-9. PubMed ID: 21319053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder.
    Hendriks GJ; Keijsers GP; Kampman M; Oude Voshaar RC; Verbraak MJ; Broekman TG; Hoogduin CA
    Acta Psychiatr Scand; 2010 Jul; 122(1):11-9. PubMed ID: 19958308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five group comparisons of treatments for anxiety disorders.
    Sharp DM; Power KG; Simpson RJ
    Br J Psychiatry; 1995 Dec; 167(6):820-1. PubMed ID: 8829755
    [No Abstract]   [Full Text] [Related]  

  • 10. Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine.
    Windhaber J; Maierhofer D; Dantendorfer K
    J Clin Psychopharmacol; 1998 Feb; 18(1):95-6. PubMed ID: 9472855
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of panic in chest pain patients from emergency departments: efficacy of different interventions focusing on panic management.
    Marchand A; Belleville G; Fleet R; Dupuis G; Bacon SL; Poitras J; Chauny JM; Vadeboncoeur A; Lavoie KL
    Gen Hosp Psychiatry; 2012; 34(6):671-80. PubMed ID: 22840563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Panic disorder and agoraphobia].
    Koga M
    Ryoikibetsu Shokogun Shirizu; 2003; (38):418-21. PubMed ID: 12877016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Panic disorder].
    Finnish Medical Society Duodecim and The Finnish Academy
    Duodecim; 2000; 116(22):2534-41. PubMed ID: 12053350
    [No Abstract]   [Full Text] [Related]  

  • 14. Different effects of selective serotonin reuptake inhibitors on a patient suffering from panic disorder.
    Masuda Y; Shimizu T
    Hum Psychopharmacol; 2004 Jan; 19(1):65. PubMed ID: 14716716
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia.
    Hendriks GJ; Keijsers GP; Kampman M; Hoogduin CA; Oude Voshaar RC
    Int J Geriatr Psychiatry; 2012 Feb; 27(2):146-50. PubMed ID: 21452176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of newer antidepressants for panic disorder.
    Gorman JM
    J Clin Psychiatry; 1997; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine augmentation in panic disorder: a case report.
    Chao I
    Pharmacopsychiatry; 2004 Sep; 37(5):239-40. PubMed ID: 15470803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in anxiety sensitivity with pharmacotherapy for panic disorder.
    Simon NM; Otto MW; Smits JA; Nicolaou DC; Reese HE; Pollack MH
    J Psychiatr Res; 2004; 38(5):491-5. PubMed ID: 15380399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y; Bakker A; Dunbar G; Judge R
    Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.